3,036,366 Shares of Common Stock Benitec Biopharma Inc. AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • April 29th, 2021 • Benitec Biopharma Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 29th, 2021 Company Industry JurisdictionBenitec Biopharma Inc., a Delaware corporation (the “Company”), proposes to issue and sell to H.C. Wainwright & Co., LLC (the “Underwriter”) an aggregate of 3,036,366 shares (the “Firm Shares”) of the common stock, par value $0.0001 per share, of the Company (“Common Stock”). The amount of the Firm Shares to be purchased by the Underwriter is set forth opposite its name on Schedule I hereto. The Company also proposes to sell to the Underwriter, at the option of the Underwriter, up to an additional 455,454 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter referred to collectively as the “Shares”. This Amended and Restated Underwriting Agreement amends, restates and supersedes in its entirety the underwriting agreement, dated as of April 27, 2021, between the Company and the Underwriter.
REED’S, INC. UNDERWRITING AGREEMENT 11,666,667 Shares of Common StockUnderwriting Agreement • October 23rd, 2019 • Reed's, Inc. • Bottled & canned soft drinks & carbonated waters • New York
Contract Type FiledOctober 23rd, 2019 Company Industry JurisdictionReed’s, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”), an aggregate of 11,666,667 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional 1,750,000 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”.
REED’S, INC. UNDERWRITING AGREEMENT 6,725,000 Shares of Common StockUnderwriting Agreement • February 15th, 2019 • Reed's, Inc. • Bottled & canned soft drinks & carbonated waters • New York
Contract Type FiledFebruary 15th, 2019 Company Industry JurisdictionReed’s, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions stated herein, to issue and sell to Roth Capital Partners, LLC (the “Underwriter”), an aggregate of 6,725,000 authorized but unissued shares (the “Firm Shares”) of common stock, par value $0.0001 per share (the “Common Stock”), of the Company. The Company also proposes to sell to the Underwriter, upon the terms and conditions set forth in Section 4 hereof, up to an additional 1,008,750 shares of Common Stock (the “Option Shares”). The Firm Shares and the Option Shares are hereinafter collectively referred to as the “Shares”.
ASTERIAS BIOTHERAPEUTICS, INC. 384,615 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2015 • Biotime Inc • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 6th, 2015 Company Industry JurisdictionAsterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions of this Underwriting Agreement (this “Agreement”), to issue and sell to MLV & Co. LLC (the “Underwriter”), an aggregate of 384,615 shares (the “Shares”) of the Company’s Series A common stock, par value $0.0001 per share (the “Common Stock”).
ASTERIAS BIOTHERAPEUTICS, INC. 384,615 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 6th, 2015 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 6th, 2015 Company Industry JurisdictionAsterias Biotherapeutics, Inc., a Delaware corporation (the “Company”), proposes, subject to the terms and conditions of this Underwriting Agreement (this “Agreement”), to issue and sell to MLV & Co. LLC (the “Underwriter”), an aggregate of 384,615 shares (the “Shares”) of the Company’s Series A common stock, par value $0.0001 per share (the “Common Stock”).
CHINA GREEN AGRICULTURE, INC. 3,500,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • July 21st, 2009 • China Green Agriculture, Inc. • Agricultural chemicals • California
Contract Type FiledJuly 21st, 2009 Company Industry Jurisdiction